All Regulation articles – Page 26
-
Business
Regulator cracks down on 23andMe
Personal genetic profiler ordered to stop selling DNA test kits
-
NewsGlobal treaty on mercury emissions signed
Ratification of the Minamata Convention may still take five years and some green groups are disappointed by its lack of ambition
-
Business
Counterfeit anxiety pills seized in Switzerland
1 million fake tablets were en route from China to Egypt
-
Business
Japan confirms Novartis clinical trial data fabrication
Investigation into blood pressure blockbuster continues
-
BusinessNew respiratory drugs neck and neck
Combination inhalers from GSK and Novartis approved in EU and Japan
-
Business
GSK criticised for trial data secrecy
Italian research institute abandons collaboration over data access
-
Business
UK objects to pesticide ban in gardens
Government disagrees with EU neonicotinoid moratorium, but will implement it
-
Business
First biosimilar antibody drugs approved in Europe
European commission gives final approval to generic infliximab copies
-
Business
Nice rules against Afinitor
Novartis’ drug will not routinely be available on the UK health service
-
Business
Syngenta takes legal action over pesticide ban
Company claims that the European commission’s two-year moratorium on neonicotinoids to protect bees was wrong
-
News
Chinese drug watchdog set for major reforms
Measures will speed up drug approvals and decentralise controls on generics
-
NewsIndian U-turn on diabetes drug ban
Suspension of cheap and popular medicine reversed but will now come with new safety warnings
-
NewsToxicologists enter the fray on endocrine disruptors
Open letter urges the European commission to consult with the scientific community before enacting any regulation
-
BusinessChina corruption investigation broadens
GSK scandal is the trigger to clean up Chinese drug market
-
Business
Monsanto abandons GM crops in Europe
Company will focus on conventional plant breeding in EU and biotech elsewhere
-
Business
Industry reaches registration deadline
Data on thousands more chemicals submitted under Reach regulations
-
News'Legal high' production gathers pace
New report highlights rapid growth in designer drugs fuelling fears that they could cause many deaths
-
BusinessIndustry applauds US chemical reform bill
Trade groups call the bipartisan bill an effective compromise, but environmental groups say it is too weak
-
Business
Portable detector shines light on fake drugs
Testing for counterfeit antimalarials in Africa will help validate a new tool for inspectors